China, Aug. 26 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy, Safety, and Pharmacokinetics of Response-Guided Sequential Triazole Therapy Following Liposomal Amphotericin B for Invasive Fungal Disease: A Prospective Cohort Study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130801
Registration Time: 2026/08/25
Type: Interventional study
Primary Sponsor: Tianjin Integrated Traditional Chinese and Western Medicine Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338194
Published by HT Digital Content Services with permission from Health Daily Digest....